Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy

NCT00957554 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00957554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00957554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2009
Completion date
September 30, 2010
Enrollment
435 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension